RA Capital Healthcare Fund LP's Form 4 filing
Fulcrum Therapeutics, Inc. (FULC) · filed Dec 16, 2022
- Accession no.
- 0001104659-22-127883
- Filed
- Dec 16, 2022, 4:41 PM ET
- Trade date
- Dec 14-16, 2022
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Not on the form (before 2023)
This filing lists 3 non-derivative transactions and 0 derivative transactions. Open-market purchases total $13.1M. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| RA Capital Healthcare Fund LPCIK 0001315082 | 10% Owner |
| Ra Capital Management, L.P.CIK 0001346824 | 10% Owner |
| Kolchinsky PeterCIK 0001384859 | 10% Owner |
| Shah Rajeev M.CIK 0001619841 | 10% Owner |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Dec 14, 2022 | Common Stock | PPurchaseAcquired | +824,600 | $5.46 | +$4,501,573.86 | 7,824,600 | Indirect | |
| Dec 15, 2022 | Common Stock | PPurchaseAcquired | +237,029 | $5.50 | +$1,302,474.36 | 8,061,629 | Indirect | |
| Dec 16, 2022 | Common Stock | PPurchaseAcquired | +1,341,420 | $5.42 | +$7,269,825.69 | 9,403,049 | Indirect |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.